Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Barry Kapik"'
Autor:
Mark R. Barakat, MD, David Brown, MD, Allen Hu, MD, Rahul N. Khurana, MD, Dennis Marcus, MD, Joel Pearlman, MD, PhD, Charles C. Wykoff, MD, PhD, Barry Kapik, MS, Thomas Ciulla, MD, MBA
Publikováno v:
Ophthalmology Science, Vol 5, Iss 1, Pp 100586- (2025)
Purpose: To evaluate the safety and tolerability of a single dose of axitinib injectable suspension (CLS-AX), a pan-anti-VEGF tyrosine kinase inhibitor (TKI), administered via suprachoroidal injection in patients with neovascular age-related macular
Externí odkaz:
https://doaj.org/article/ff6174f6c3444b01bcdabdb6dcbdd020
Publikováno v:
Ophthalmology and Therapy. 12:577-591
Autor:
Barry Kapik, Debra A. Goldstein, Quan Dong Nguyen, Rahul N. Khurana, Mark R. Barakat, Thomas A. Ciulla, Thomas A. Albini, Emmett T. Cunningham, Dilraj S. Grewal
Publikováno v:
American Journal of Ophthalmology. 237:310-324
PURPOSE To assess the relationship between best corrected visual acuity (BCVA) and central subfield optical coherence tomography (OCT) features in noninfectious uveitis (NIU)-related macular edema (ME). DESIGN Clinical cohort study from post hoc anal
Autor:
Swetha Bindu Velaga, Muneeswar Gupta Nittala, Ahmed Roshdy Alagorie, Jyotsna Marram, Zhihong Jewel Hu, Ziyuan Wang, Thomas A. Ciulla, Barry Kapik, Srinivas R. Sadda, Michael Ip
Publikováno v:
Canadian Journal of Ophthalmology.
Autor:
Steven Yeh, Pauline T. Merrill, Barry Kapik, Michael A Singer, Thomas A. Ciulla, Colette Hall
Publikováno v:
Clinical & Experimental Ophthalmology. 50:23-30
Background This post hoc analysis compared the efficacy and safety of CLS-TA to other commonly available treatments for noninfectious uveitis (NIU). Methods Results from the PEACHTREE study were compared between subjects randomized to CLS-TA not requ
Publikováno v:
Ophthalmol Retina
PURPOSE: To assess the relationship between best-corrected visual acuity (BCVA) and anatomic features in patients with macular edema (ME) related to retinal vein occlusion (RVO). DESIGN: Post hoc analysis of 3 clinical trials, which included verified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce3e30e6715b729ff0c01f341830eee
https://europepmc.org/articles/PMC9927025/
https://europepmc.org/articles/PMC9927025/
Autor:
Thomas A. Ciulla, Quan Dong Nguyen, Ashvini K. Reddy, Christopher R. Henry, Barry Kapik, Pauline T. Merrill
Publikováno v:
Ocular immunology and inflammation.
PURPOSE To study the efficacy and safety of suprachoroidal CLS-TA (proprietary suspension of triamcinolone acetonide) in uveitic macular edema (UME) with and without concurrent systemic corticosteroid or steroid-sparing therapy (ST). METHODS Post hoc
Publikováno v:
Ophthalmology Retina.
PURPOSE This study assessed relationships between best-corrected visual acuity (BCVA), central subfield thickness (CST), and ellipsoid zone (EZ) integrity in macular edema (ME) patients. DESIGN Post hoc analysis of 6 clinical trials, which included v
Publikováno v:
Ophthalmology. Retina. 5(7)
This study assessed relationships between best-corrected visual acuity (BCVA), central subfield thickness (CST), and ellipsoid zone (EZ) integrity in macular edema (ME) patients.Post hoc analysis of 6 clinical trials, which included verified diagnose
Autor:
Barry Kapik, Faruque Ghanchi, Daniel M. Miller, Craig M. Greven, Baruch D. Kuppermann, Michael A Singer, Clare Bailey, Jeffrey G. Gross
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 49:698-706
BACKGROUND AND OBJECTIVE: Visual outcomes of the FAME study (0.2 μg/day fluocinolone acetonide [FAc]) and Protocol I (0.5 mg ranibizumab plus deferred laser) were compared using the area under the curve (AUC) analysis method. PATIENTS AND METHODS: B